Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.
about
Methanesulfonyl ChlorideThree-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study.Development and strategies of VEGFR-2/KDR inhibitors.Three-dimensional pharmacophore screening for fentanyl derivatives.Chemistry and biology of multicomponent reactions.The Gewald multicomponent reaction.Update on lymphocyte specific kinase inhibitors: a patent survey.Epidermal growth factor receptor inhibitors: a patent review (2010 - present).Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.Synthesis and Antitumor Activities of Chiral Dipeptide Thioureas Containing an Alpha-Aminophosphonate Moiety.Synthesis, in vitro Anticancer and Antimicrobial Evaluation of Novel Substituted Dihydropyrimidines.Synthesis and anticancer activity of some novel fused pyridine ring system.Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitors.Aminodi(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, effects in human tumor cells growth, cell cycle analysis, apoptosis and evaluation of toxicity using non-tumor cells.In vitro inhibition of translation initiation by N,N'-diarylureas--potential anti-cancer agents.Synthesis and biological evaluation of novel N, N'-disubstituted urea and thiourea derivatives as potential anti-melanoma agents.Synthesis and biological evaluation of novel (thio)urea derivatives as potential antitumor agents.Synthesis, biological evaluation, and molecular modeling of 3,5-substituted-N1-phenyl-N4,N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents.1-aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR-2 tyrosine kinase inhibitors: synthesis, biological evaluation, and molecular modelling studies.Synthesis and Bioevaluation of Thieno[2,3-d]pyrimidinone Derivatives as Potential Tumor Cell Growth Inhibitors
P2860
Q29303118-B7691CA8-51E1-4377-9C94-59B1E6F54BD9Q34286658-2A66A5AF-A67D-46E5-9BC3-2E3D54B03AD8Q34436101-F8121CB1-A380-4BCB-A51E-67CDC12C866CQ35020835-EE90B18B-9ECA-4344-8180-DE41977CC552Q37017587-69DE9D0F-475C-4B0B-B09A-19766FEF610FQ37700274-42655711-F212-4AA6-98E8-A21AABBB597DQ37787241-39C1BF23-2F30-4A1B-B957-C1AD2C0A4C5AQ38175432-3A9B657B-1B9B-4E8F-A4FD-520C6963A71AQ38701634-4E0E69D1-C866-464A-8F5A-A468433A59D8Q38716036-491E7436-7F0A-4191-9710-2349E6AC41A6Q38950357-A8F656CF-BCF6-4567-9297-F8D6F9B23968Q39232196-2DD6C760-9F04-442B-AB5F-5798645DA908Q39268499-825D5244-64CA-4EAC-A7B1-4460E0ABB33CQ39372668-CE2AF387-94B6-4A3E-ADA3-98C0F5017615Q39431410-DB769AB3-21D7-4EF1-844E-EA617248EA93Q39460714-0A232F75-A100-4275-B8BA-BC9012D5CDEAQ39466369-BE05E8CA-3A2D-4DD3-AE69-BAD634C08561Q40109825-C402CBD1-50EA-407F-ACC0-5ADDD2327C64Q41851477-3F9321C7-D392-41D4-9B21-E6EBD5AF16B4Q59010648-21C09267-C4CC-42E3-B0F6-077A951C8C3E
P2860
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@en
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@nl
type
label
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@en
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@nl
prefLabel
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@en
Thienopyrimidine ureas as nove ...... or tyrosine kinase inhibitors.
@nl
P2093
P356
P1476
Thienopyrimidine ureas as nove ...... tor tyrosine kinase inhibitors
@en
P2093
Asma A Ahmed
Daniel H Albert
George A Cunha
Jennifer J Bouska
Joy L Bauch
Junling Li
Keith B Glaser
Kennan C Marsh
Lee Arnold
P304
P356
10.1021/JM050458H
P407
P577
2005-09-01T00:00:00Z